Depression Treatment News

2011-04-09 / Mental Health / No Comment

Post-Stroke Depression Treatment Improves Chances of Functional Recovery

SAN ANTONIO – Preventing or treating depression after a stroke can help patients with varying degrees of disability and adaptive skills recover functional ability.

Treatment for depression can help patients develop the plasticity they need to recover physical function, or in the case of more serious poststroke disabilities, help them more readily adapt to their limitations, Dr. Ellen M. Whyte said at the annual meeting of the American Association for Geriatric Psychiatry.

Viagra super active uk

Both the brain’s plasticity and adaptation rely on the ability of patients to practice and learn new skills to help themselves recover or adapt after a major medical illness such as a stroke. But evidence from several studies shows that “depression after a stroke is associated with poor functional recovery and decreased efficiency of recovery,” said Dr. Whyte, a geriatric psychiatrist at the University of Pittsburgh.

Decreased Participation. Depression may impede recovery from a stroke by decreasing a patient’s participation in rehabilitation activities, she said. Depression is also associated with cognitive problems, such as executive impairment, that can interfere with recovery or adaptation, and with motor impairment, such as decreased gait speed, which may also hinder rehabilitation.

A 2004 study from the University of Pittsburgh of 242 patients admitted for rehabilitation showed that patients who were “frequent poor participators” in rehabilitation activities had less physical recovery and longer length of stay, and were more likely to be institutionalized than either occasionally poor participators or good participators (Arch. Phys. Med. Rehabil. 2004;85:1599-601).

A separate study by Dr. Whyte and her colleagues looked at the effects of mood, apathy, memory, attention, executive function, and level of disability on participation in rehabilitation. The patients all had evidence of cognitive impairment, but they were without major depression.

The investigators found that among the 44 stroke survivors aged 60 years and older who were admitted for inpatient rehabilitation, baseline disability and impairment of executive function were independent predictors of participation. They also found that “while level of depressive symptoms was not an independent predictor of rehabilitation participation in this sample, it was strongly correlated with executive functions. Depressive symptoms and impairment in executive functions frequently overlap in late life and after stroke, and potentially represent ischemic injury to frontal-subcortical pathways” (Arch. Phys. Med. Rehabil. 2010;91:203-7).

Falls and Depression Linked. Other studies found that depression, as measured by the Symptom Checklist-90, was associated with a doubling of falls in community-dwelling adults aged 70 years or older (J. Clin. Epidemiol. 2002;55:1088-94), and that poor self-rated health, poor cognitive status, impaired activities of daily living, two or more clinic visits in the past month, and slow walking speed predicted both an elderly patient’s risk of falling and depressive symptoms (J. Epidemiol. Community Health 2002;56:631-6), she said.

Additionally, investigators looking at the effect of depression remission after a stroke found that patients with remission of a depressive disorder at follow-up had significantly greater recovery in activities of daily living (ADL) functions than did patients without remission. The authors also found that patients with remission of either major or minor depression showed greater improvement in ADL than did patients without remission, some of whom had received the antidepressant nortriptyline, and some of whom had received placebo. The finding suggests that nondrug mechanisms of recovery from depression may have accounted for the improvements in ADL among patients with remission (J. Nerv. Ment. Dis. 2001;189:421-5).

The evidence points to a stroke-recovery model in which preventing or treating depression would lead to increased motivation and participation in rehabilitation programs, reduced depression-related cognitive impairments, and decreases in depression-related motor impairments, Dr. Whyte said.

Dr. Whyte receives research support from the National Center for Medical Rehabilitation Research. She has previously received research support from Eli Lilly, Forest Pharmaceuticals, Ortho-McNeil, Pfizer Pharmaceuticals, and the National Institute of Mental Health.

Promising new depression treatment

A new, non-invasive treatment for depression that delivers barely perceptible electric currents to the scalp has had promising results in a Sydney trial, and researchers are now looking for participants for a follow up study.

Around half of depressed participants in the trial of transcranial Direct Current Stimulation (DCS) experienced substantial improvements, according to a team of researchers based at the Black Dog Institute and the University of New South Wales (UNSW).

An even larger number enjoyed a clinically meaningful improvement, said study leader, Professor Colleen Loo, from UNSW’s School of Psychiatry. The team is now preparing the results for academic publication.

“These are excellent outcomes when you consider that most of these people had depression that had not responded to other treatments, including medication,” Professor Loo said. “What’s more, further benefits were sustained when we followed people up a month later. That’s an exciting result.”

The trial, the largest of its type in the world, involved stimulating frontal areas of the brain with very small, barely perceptible currents, while patients remained awake and alert. The procedure has no known serious side effects.

“Direct Current Stimulation primes the neurons so that, when they are triggered, their response is enhanced. This trial is suitable for patients seeking an alternative to medication or who are unable to tolerate anti-depressant drugs or Electroconvulsive Therapy (ECT),” Professor Loo said.

Studies in the 1960s and 70s reported good results using small electrical currents over a few hours. From 2000, the technique has been further developed, using currents of 1-2 milliamps. Recently, two small overseas studies found promising improvements in depressed patients treated with DCS.

The UNSW researchers are planning another trial to further investigate the optimal way to administer DCS. To begin later this month, the trial is recruiting around 120 people to receive DCS for 20 minutes, five times a week over four to eight weeks. Participants can attend the clinic on an outpatient basis.

Treatment for depression a long-term solution

(Edmonton) Ian Colman, an epidemiologist in the School of Public Health at the University of Alberta, recently completed a study that suggests that treatment of depression may have long-term benefits.

The data Colman reviewed came from the National Population Health Survey, a longitudinal Canadian study, and showed depressed adults who use antidepressants are three times less likely to be depressed eight years later, compared to depressed adults who don’t use antidepressants.

To date, research into the effects of antidepressant treatments for individuals with major depression has only concentrated on short-term outcomes says Colman, and that there is limited knowledge about long-term results.

However, it’s important to note that it’s unlikely that the effects are just the result of ongoing treatment; Colman says, “It’s more likely that results from the study speak to the importance of getting evidence-based treatment, drugs or other therapies, in the first place and treatments that ensure that all of your symptoms are resolved.”

Colman also stresses that, while proper treatment is vital, he also points the importance of treatment that continues until an individual’s symptoms have completely ceased.

“It’s common that depressed individuals will have a partial remission of symptoms where they feel better but some symptoms remain; those people have poor long-term outcomes,” he says. “It’s important to have successful treatment that deals with all of your symptoms.”

The study, Colman hopes, will shed even more light on a complex issue. While depression can be a difficult topic to discuss in everyday conversation, recent research has shown more than 50 per cent of people who are depressed are not receiving treatment, possibly because, Colman says, they don’t recognize symptoms, don’t want treatment, or are not getting appropriate treatment due to stigma around mental illness.

Colman offers several options in order for treatment to be successful. Psychotherapy and cognitive behavioural therapy, which focuses on problem solving and skills building, help the patient deal with stressful situations for example, and have proved to have long-term beneficial outcomes.

“Evidence suggests that cognitive behavioural therapies are as effective as anti-depressants, and the two treatments together is even more effective,” he says.

Pointers for responsible reporting on mental health

Meyers said on the show: “The conference is organised for South African journalists by the South African Depression and Anxiety Group (SADAG) and the Carter Centre Mental Health Programme, based in Atlanta, Georgia.” Meyers explained on the radio show that the Carter Centre encourages journalists to explore and write about mental health issues, to gain understanding of the technical issues involved with mental health issues and that he would raise questions at the conference on how journalists make sense of the often very technical information provided by doctors, psychiatrists and psychologists.

I attended the second day of the conference, held at the Pfizer building in Sandton on Monday, 4 and Tuesday, 5 April. The second day of the seminar kicked off with a welcome by the Master of Ceremonies, Marion Scher, who is a freelance journalist and a Carter Fellow. She stated that there is a lack of knowledge out there, and that as a result, mental disease becomes “a silent illness”. It is not perceived as serious, and we need to get this awareness out there through the media.

SADAG’s founder, Zane Wilson, introduced the day’s first speaker, Dr Leigh Janet, who deals with “some of South Africa’s most difficult, treatment-resistant patients”. He is a psychiatrist, psychopharmacologist and expert in Bipolar Mood Disorder, who presented on ‘Riding the emotional rollercoaster – understanding Bipolar Mood Disorder’. He likened Bipolar Mood Disorder to the ‘emotional rollercoaster’ you would ride if we were to win the soccer, cricket and rugby world cups on the same day – then to find out a loved one has been booked into hospital and since died. He said, “Now imagine your mood moving like that for no reason,” calling Bipolar the most interesting disorder on the planet as one can have periods of ‘normal mood’ for years, and other conditions can co-occur with the disorder. He added that the mood swings, which range from depression to mania, “don’t feel abnormal to the person at the time.” It is also one of the top disorders associated with suicide and depression, and is linked to strong feelings of guilt. Interestingly, ECT, or electric shock therapy, is often used as treatment in an attempt to imitate a series of epileptic fits, which can be seen to cure depression.

This was followed by an off-the-record case study of a patient who lives with Bipolar Mood Disorder, where she described the prejudices she has faced in the workplace and within her own family, along with the difficulty she has had in convincing people that a mood disorder is as real a disease as diabetes or cancer. It’s a fight to get people to listen. She added that this is made worse by the fact that “government is interested in AIDS and TB, not mental illness.”

Next, Dr Shadi Motlana, Director of Psychiatry M Powered, took to the podium. As the head of Psychiatry at Tara Psychiatric Hospital, she elaborated on mental health patients’ rights and the Mental Health Care Act. She feels that Tara is misunderstood, particularly in the way it screens its patients. In explaining the rights of the mentally ill in South Africa, Motlana stated that the many abuses of government during the Apartheid era were redressed with 2002’s Mental Health Care Act, which sought to bring our practices in line with those of the World Health Organisation (WHO) and the African Banjul Charter. Mental Health Care Users (MCHU) of today have the right to respect, protection from unfair discrimination, and the right to intimate adult relationships, as well as knowledge of their rights and the right to appeal. Care treatment and rehabilitation must therefore not be used as punishment or for the convenience of others. Motlana added that the workplace should be made aware of any mental illness as there are reasonable protections in place by the law. She stated, “Silence causes more problems down the line.” She added that certain terminology is problematic, and that there is lots of discriminatory thinking regarding mental health issues. “The obligation lies with reporters to watch how they report on stories and to not exaggerate the facts or ostracise anyone,” Motlana said. Responsible reporting on mental health can destigamatise and raise awareness of mental health issues, getting people comfortable with the topic, so that they realise, “This doesn’t have to be your destiny” – it can be treated. She applauded SADAG for its role in making mental health issues visible to the public eye in terms of raising awareness. Wilson added that it would cost roughly R20 000 per month to run a 24-hour suicide line – the group can currently only afford to run the line from 08:00 to 20:00.

We then heard from Peter Matlhaela, the Siyabuswa Support Group Leader, who discussed the complications of getting patients’ care in a rural community, in an interview session with SADAG’s Operations Director, Cassey Chambers. He described his ordeal in dealing with panic attacks following his involvement in a taxi accident, and highlighted the fact that there is lots of stigma or lack of knowledge concerning mental health problems in the rural areas, adding that many people in these areas are illiterate and needed support groups so as to reach the people and educate them in the way they would understand. He said a key issue affecting understanding is that some African cultures lack separate words for depression and panic attacks, lumping them all together as ’madness’ – and if there’s no word for it, how would they understand it? Matlhaela gets around this problem by getting support group attendees to act out how they feel.

Following a tea break, Kevin Bolon, a clinical psychologist and Cognitive Behavioral Therapy (CBT) expert who has developed a course for the fear of flying, spoke about how obsession and compulsion go hand in hand, offering an insight into Obsessive Compulsive Disorder (OCD). He explained that many psychological terms have become popular and are now in everyday use, such as ‘depression’ and ‘panic attack’ – he stated that mental disorders are debilitating and should not be treated lightly – much in the way that anyone with a runny nose and sore throat claims to have the flu, which is actually a serious, potentially fatal illness. He mentioned that washing and counting are among the most common compulsions, and that prayer often gets hijacked into compulsion, in that we feel a need to pray when we think a ‘bad thought’ – the act of praying works to ease our anxiety. He added that the compulsions are targeted in treatment, so that eventually the patient is less likely to feel a need to react a certain way when a certain thought crosses their mind, because they are associating a consequence with a certain unrelated behaviour – this is known as ‘magical thinking’ as people connect a cluster of ‘what ifs’ to reach an unlikely outcome. It is also known as the ‘doubting disease’ because of this. The compulsion only results in a temporary release of anxiety as it reloads. Bolon reassured attendees that “we all have bits of OCD behaviour”, but actual diagnosis is based on the amount of time spent on the compulsions, as well as the level of impairment or interference caused in day-to-day functioning. He added that there is a risk of misdiagnosis and that people are becoming more aware of the disorder due to it receiving greater coverage in articles and TV shows. It is not treated with Cognitive Behavioural Therapy, which aims to change thoughts during the behaviour – instead, an ‘exposure and response prevention’ method is used, where the patient is made to face their obsession trigger and resist the compulsion. The thoughts get weaker and weaker as treatment goes on. OCD only gets worse if it is not treated as it acts as an addiction. Traditional therapy is also not effective in treatment of OCD as going through past traumas can make OCD worse. Antidepressants are also used to boost levels of serotonin – but not because there is a lack of serotonin or the person is depressed. Bolon explained this is similar to the fact that Panado is used to cure a headache even though a lack of Panado is not the cause of the headache. He asserted that mental health issues are often misrepresented in the media, and that there is no such thing as ‘compulsive’ shopping or gambling, as these are based on impulses.

SADAG Counsellor, Shai Friedland, then gave a personal account of living with OCD, titled, ‘When worry hijacks the brain: An OCD patient takes back his life.’ He shared his typical obsessive thought processes and explained that anyone who suffers from mental health issues is “not a freak – it’s a disorder”. To this, Bolon added, “These people are not weird or strange – they are as normal as you and me. They are normal people dealing with abnormal situations.” SADAG’s Project Manager, Roshni Parbhoo-Seetha, spoke about creating mental health awareness and developing successful school outreach programmes. SADAG promotes several mental health awareness days to raise awareness, as well as school prevention programmes, such as ‘Suicide shouldn’t be a secret’ and ‘When death impacts your school’ in order to discuss the warning signs in a safe environment, as teenagers don’t seem to understand the permanence of the act and it is sometimes seen as a way to attract attention. Wilson interjected that SADAG has revamped its website (www.sadag.org), which is a valuable resource for mental health journalists as it includes local and international articles on many topics. She also provided surprising statistics from a survey taken the previous day that proved 30% of the journalists attending the conference suffer from mild depression, 25% from major depression, with one so high that the person might be verging on suicide. A definite sign that there’s a need for better education on the topic!

After a lunch break, Clinical Psychologist, Robyn Rosin, spoke on the topic of ‘Flashbacks: when the worst thing that ever happened to you keeps happening everyday’ in the sense of treating Post-Traumatic Stress Disorder (PTSD). She stated that the media has a great role to play in terms of getting factual information out there and breaking the stigma of mental health disorders. She said knowledge of PTSD is especially important to field reporters who are at the scene of horrible accidents and violence, often taking horrific images as photojournalists, which continue to haunt them for years. It is also known as vicarious or secondary traumatisation if journalists hear traumatic stories and need to recount them. She added that we like to feel our world is safe and predictable, and we think that “bad things happen to other people” – this is why it is such a shock when something bad happens to us. For the first 24 to 48 hours after experiencing a traumatic event, the typical reaction is to feel numbness and disbelief as we try to make sense of what has happened – debriefing is often essential to put the event into perspective. This involves education and ‘normalising’ the symptoms in order to redress the trauma experiences and put them into perspective, understanding that the symptoms are normal. PTSD is only diagnosed if symptoms persist for a month after the event which triggered the symptoms and is easy to trace. Rosin echoed Bolon’s words, that mental illness is “a normal reaction to an abnormal set of circumstances.” Treatment revolves around getting the person back to their normal state of functioning as soon as possible.

Meyers then presented the final session of the day, on ‘Presenting to editors, producers and supervisors: how to portray your story’. This was a workshop brainstorming session where attendees broke into small groups to discuss possible article ideas based on the topics that had been presented for the day. He spoke of the importance of using a common/ neutral language that does not make mental health patients sound deficient in any way, adding that standards differ greatly among different media, ad that there has been a “coarsening of civil dialogue,” which is why so many newspapers lead with shocking images of bodies splattered on the ground and graphic images of violence.

Rebecca Palpant, Assistant Director of the Rosalynn Carter Fellowships for Mental Health Journalism, concluded the session by stating, “This is just the beginning for mental health journalism in South Africa,”adding that personal stories are so powerful – stories about mental health should not quote numbers, they should speak of the singular self that is affected. Scher interjected that interested parties should enter the Pfizer Awards for mental Health Journalism through the SADAG website, which results in two awards of R25 000 for mental health journalists.

Best Supplements for Depression

Far from just a “down in the dumps” day or two, depression is a serious illness that affects about 12 million women in America each year. It can cause energy levels to plummet, changes in sleeping and eating patterns, problems with memory and concentration, and feelings of hopelessness, worthlessness, and negativity.

Many different factors can cause depression (it’s usually a combination of genetic, environmental, and psychological issues) and there’s rarely a one-size-fits-all treatment. People with severe depression seem to have a brain chemistry that predisposes them to bouts. It’s important to see a doctor if you experience five or more of these depression symptoms for more than 2 weeks: persistent sad, anxious, or empty feelings; loss of interest or pleasure in activities; feelings of hopelessness, pessimism, guilt, worthlessness, or helplessness; insomnia or oversleeping; appetite loss or overeating; fatigue; restlessness; irritability; difficulty concentrating or remembering; or thoughts of death or suicide.

Tired all the time? If you can’t pinpoint why you’re so fatigued, these tests can help you determine why you’re dragging

Depression is usually treated with some combination of medications, therapy, and lifestyle changes. Antidepressant drugs are commonly a primary treatment for adults with moderate to severe cases. It can take some trial and error to find the med that works best for you, and can take up to 3 months for the med’s effects to kick in. Research shows that talk therapy helps beat depression too; up to two-thirds of people could recover just as well from therapy alone, skipping drugs entirely. Exercise is also a proven natural remedy—in one study, people with mild to moderate depression who started exercising 3 to 5 times a week improved depressive symptoms like anxiety and insomnia by 47%.

Certain supplements may also help manage depression.

Best supplements:

St. John’s Wort: This popular herb has been used to treat depression for centuries. One major review found that it was as effective as standard drugs in many cases, although evidence suggests it’s not as helpful for people who are severely (compared to mildly) depressed. SJW may work by helping to rebalance levels of brain chemicals linked to mood, like dopamine and serotonin. The big warning sign with SJW, though, is that it interacts with many different medications (including some antidepressants), so you should always check with your doctor before you take it.

Omega-3s: Numerous studies have found that heart-healthy fish oil may also benefit your brain and mood. A big study in the Journal of Clinical Psychiatry found that omega-3 intake significantly improved depression and certain other psychiatric conditions. Although some study results are mixed, there are many other healthy reasons to eat fish or take a fish oil supplement, and many experts agree it’s a good idea to use it in conjunction with other depression treatments.

SAMe: Short for S-adenosylmethionine, this naturally occurring compound in your body helps boost brain chemicals serotonin and dopamine; low levels of both are implicated in causes of depression. Research shows SAMe is as effective as many antidepressant meds.

Read More

Asthma Treatment News

2011-04-08 / Asthma / No Comment

Researchers Aims to Develop a Vaccine to Cure Asthma Completely\

“Monash University researchers are working on a vaccine that could completely cure asthma brought on by house dust mite allergies. If successful, the vaccine would have the potential to cure sufferers in two to three doses. Allergies to house dust mites is a leading cause of asthma and the respiratory condition affects more than 2 million Australians and costs more than $600 million in health expenditure each year.” http://starglobaltribune.com/2011/allergy-medication-researches-developing-vaccine-for-the-complete-cure-of-asthma-7019

Now, people are allergic to dust mites and must frequently clean their environment in order to remove the microscopic creatures that cause allergic attacks. There were some medications that bring relief to the problem, but the medication must be taken regularly. Others reported that they have responded less well to the medications.

Professor El Mauseen believes that a vaccine for people who have allergy in house dust mite will have a series of health and financial benefits for the patient as well as to the government. Professor Mauseen is working with Professor Robyn O’Hehir, both from the Faculty of Medicine, Nursing and Health Services. Professor Maureen said that their goal is to develop a vaccine that can completely bring in two or three doses. That means that those who suffer from a house dust mite allergy will have an easy breath of air from their final dose.

The cost of allergy from the Australians reach approximately seven billion dollar each year. Professor O’Hehir also made an important gain in developing a vaccine for those who have allergy in peanut. There is no specific treatment for the allergy in peanut; hence the only option for that are avoidance and the emergency treatment of anaphylaxis with adrenaline.

Laboratory testing has shown that genetic predisposition exists to be allergic to more than one allergen. Dr. Meeusen said that they have found out the being allergic to peanut also has likelihood in developing allergy to house dust mites. It is difficult to human to know how early the stage of allergy occurs. The scientists will see which models are going to build up allergy and which are not, that is to resolve the difference between the two.

Using the knowledge of normal vaccines for infectious diseases will help researchers to have a good understanding on how the allergy vaccines work in order to develop a more safe and effective product.

Effects of short-term treatment with atorvastatin in smokers with asthma – a randomized controlled trial

The immune modulating properties of statins may benefit smokers with asthma. We tested the hypothesis that short-term treatment with atorvastatin improves lung function or indices of asthma control in smokers with asthma.

Methods: Seventy one smokers with mild to moderate asthma were recruited to a randomized double-blind parallel group trial comparing treatment with atorvastatin (40 mg per day) versus placebo for 4 weeks.

After 4 weeks treatment inhaled beclometasone (400 ug per day) was added to both treatment arms for a further 4 weeks. The primary outcome was morning peak expiratory flow after 4 weeks treatment.

Secondary outcome measures included indices of asthma control and airway inflammation.

Results: At 4 weeks, there was no improvement in the atorvastatin group compared to the placebo group in morning peak expiratory flow [-10.67 L/min, 95% CI -38.70 to 17.37, p=0.449], but there was an improvement with atorvastatin in asthma quality of life score [0.52, 95% CI 0.17 to 0.87 p=0.005]. There was no significant improvement with atorvastatin and inhaled beclometasone compared to inhaled beclometasone alone in outcome measures at 8 weeks.

Conclusions: Short-term treatment with atorvastatin does not alter lung function but may improve asthma quality of life in smokers with mild to moderate asthma.

Reminder: MediciNova to Host Business Update Conference Call by Management on April 7, 2011

SAN DIEGO, April 7, 2011 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced details on its planned business update conference call conducted by management today, Thursday, April 7, 2011 at 4:30pm(Eastern).

Conference Call/Webcast Information

MediciNova will host a conference call and audio webcast to make a business update presentation followed by a question and answer session with members of management. Management on the call will include Dr. Yuichi Iwaki the President and Chief Executive Officer, Michael Coffee the Chief Business Officer and Interim-Chief Financial Officer, and Dr. Kirk Johnson the Chief Scientific Officer. The call is scheduled for today, April 7th, at 4:30 P.M. Eastern time.

To participate in this call, dial 866-203-2528 (domestic), 617-213-8847 (international), passcode: 61797215, shortly before 4:30 P.M., Eastern time. For a limited period following the call, a replay of the call will be available, beginning at 7:30 P.M. Eastern time; the replay can be accessed by calling 888-286-8010 (domestic), 617-801-6888 (international), passcode: 52603635. The audio webcast will be available on MediciNova’s investor relations website (http://investors.medicinova.com) for approximately 60 days following the call.

About MediciNova

MediciNova, Inc. is a publicly traded biopharmaceutical company founded upon acquiring and developing novel, small-molecule therapeutics for the treatment of serious diseases with a commercial focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential, and patent coverage of commercially adequate scope. MediciNova’s pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis, solid tumor cancers, Generalized Anxiety Disorder, preterm labor and urinary incontinence and two preclinical-stage compounds for the treatment of thrombotic disorders. MediciNova’s current strategy is to focus on its two prioritized product candidates, MN-221, for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease exacerbations, and Ibudilast (MN-166/AV411), for the treatment of multiple sclerosis, chronic pain, spinal cord injury, or drug addiction. Each drug candidate is involved in clinical trials under U.S. and Investigator INDs. MediciNova is engaged in strategic partnering discussions to support further development of the MN-221 and Ibudilast programs. Additionally, MediciNova will seek to monetize opportunistically its other pipeline candidates.

Don’t Let Seasonal Allergies Spoil Your Spring

The arrival of spring means warmer temperatures, open doors and windows, and the start of allergy season are all on the way. Instead of putting up with weeks of sniffling, sneezing, and itching eyes, try these tips from the American College of Allergy, Asthma and Immunology to keep your allergy symptoms under control.
This Article
Improved My Health
1
Changed My Life
Saved My Life

• Know your allergens – Your allergen is the thing you are allergic to. It could be pollen from certain plants that bloom in the spring, or it could be something that is around year ’round. More than two-thirds of all people who think they have spring allergies actually have allergies all year. Knowing what you are allergic to can help you decide when it’s time to start treatment. An allergist can determine what your allergens are and set up a plan to help you deal with them.

• Get the best meds – There are many over-the-counter (OTC) medications available that claim to be the best thing to treat allergies. If one treatment doesn’t work, you may be tempted to just keep buying and trying new things in the hope that something will do the job. Rather than spending money randomly, consider meeting with an allergy specialist who can isolate your allergen and prescribe the best medication to treat your symptoms. In general, prescription medications are better at treating a stuffy nose and inflammation in the sinuses. Another option that can provide long-term relief is immunotherapy. This treatment involves weekly allergy shots to help your body learn not to react to your allergen.

• Take meds on time – If you wait until your nose is stuffy and you are miserable to take allergy medications, you will have an uphill battle to feel better. If you know that your allergies kick in during the spring, start taking your medication before your symptoms can get a head start. Warm weather generally means the start of allergy season when plants release pollen and molds resume growing.

• Avoid your allergens – The less you are around your allergens, the less you will have symptoms. So stay indoors during the middle of the day when pollen counts are highest.

Read More

Cancer Prevention News

2011-04-07 / Cancer News / No Comment

Frozen Strawberries, Key To Throat Cancer Prevention In China

In a country where there is the highest incidence of throat, or esophageal cancer, Chinese researchers have found that simple strawberries may be an affordable and commonly found prevention tool to stave off this deadly disease. Frozen berries are even better because by removing the water from the berries, the concentrate of the preventive substances increase by nearly tenfold.

Lead researcher Tong Chen, M.D., Ph.D., assistant professor, division of medical oncology, department of internal medicine at The Ohio State University and member of the Molecular Carcinogenesis and Chemoprevention Program in The Ohio State University Comprehensive Cancer Center explains:

“We concluded from this study that six months of eating strawberries is safe and easy to consume. In addition, our preliminary data suggests that strawberries can decrease histological grade of precancerous lesions and reduce cancer-related molecular events.”

Study participants consumed 60 grams of freeze dried strawberries daily for six months and completed a dietary diary chronicling their strawberry consumption.

The researchers obtained biopsy specimens before and after strawberry consumption. The results showed that 29 out of 36 participants experienced a decrease in histological grade of the precancerous lesions during the study.

Chen continues:

“Our study is important because it shows that strawberries may slow the progression of precancerous lesion in the esophagus. Strawberries may be an alternative or work together with other chemopreventive drugs for the prevention of esophageal cancer. But, we will need to test this in randomized placebo-controlled trials in the future.”

If the cancer is diagnosed in its earliest stages, the patient’s chances of living and being cancer free five years after treatment is greatly improved. Unfortunately, most cases of esophageal cancer are only discovered when the patient comes to their doctor because of swallowing difficulty, which doesn’t happen until later stages of the cancer growth. The prognosis then is very poor.

Esophageal cancer is a relatively rare form of cancer, but some world areas have a markedly higher incidence than others: Belgium, China, Iran, Iceland, India, Japan, the United Kingdom, appear to have a higher incidence, as well as the region around the Caspian Sea. The American Cancer Society estimates that during 2011, approximately 16,000 new esophageal cancer cases will be diagnosed in the United States.

Since the 1960s, Chinese researchers at the Cancer Institute, Chinese Academy of Medical Sciences, have been tracing the environmental factors that cause esophageal cancer.

Esophageal cancer is the eighth most common cancer and the fifth most common cause of cancer deaths in the world. About 250,000 esophageal cancer cases are diagnosed each year in China, accounting for half of the world’s total.

Once diagnosed, survival rates for esophageal cancer are poor: 75% of patients die within one year, and the five-year survival rate is only 5% to 10%.

Esophageal cancer occurs more often in specific regions. Most victims live in the “esophageal cancer belt,” which stretches from the central part of North China westward through Central Asia to northern Iran.

In China, esophageal cancer occurs mainly in areas south of the Taihang Mountains on the borders of three provinces Henan, Shanxi and Hebei.

Media Advisory – Annual Report Card on Cancer in Canada(TM) – Fighting a Battle on Two Fronts: the Disease and the System

Media are invited to join the Cancer Advocacy Coalition of Canada (CACC) for the release of the 2010-2011 Report Card on Cancer in Canada™ and presentation of key findings:

● Cancer Prevention in Canada: The sooner the better
Prevention is the single most cost-effective initiative Canada could implement to combat many cancers and data show it would result in several thousand fewer cases each year and millions of dollars in savings for governments. Despite this compelling evidence, Canada is lacking dedicated cancer prevention centres and organized cancer prevention programs.

● Should clinical trials be considered the standard of care for cancer patients in Canada?
Clinical trials are the engine that drives cancer research and have been the source of major advances in our understanding of cancer cell biology and treatments. Participation in clinical trials allows people with cancer to access potentially effective new treatments, and institutions with high participation rates in academic clinical trials have better patient outcomes. But, Canada is rapidly falling behind other countries in its capacity to undertake patient-oriented research.

● The Role of the Nurse Practitioner and Clinical Pharmacist in Collaborative Patient Care and Drug Therapy Management in Canadian Cancer Centres
Due to an aging population, the prevalence of cancer in Canada will continue to increase and the rise in the volume of patients will need to be met with an expansion of oncology services. Cancer treatments are moving from the hospital setting to the home, creating a gap in patient care and oversight. Expanding the role of non-physician healthcare professionals should be addressed.

● Rare Cancers and Advocacy
The need to support patients living with rare cancers, such as testicular and ovarian cancer, is urgent. They face unusual hurdles in diagnosis, treatment and recovery while public attention is focused on the big-number cancers. Though there have been significant advances in treatment options and therapies, many patients with rare cancers are still struggling for access to the services they need. Scores of patients, along with their physicians, become advocates just to be heard.

WHERE: The Royal Ontario Museum, 100 Queen’s Park, Toronto, Ontario
Level 4 RBC Foundation Glass Room (Queen’s Park/Avenue Road entrance)

WHEN: Tuesday, April 12, 2011
9:45 a.m. – Media sign-in
10:00 a.m. – News conference begins
11:00 a.m. – News conference ends, one-on-one interviews available
The full Report Card and all related materials will be on the CACC website by 10.00 a.m. the morning of the news conference at www.canceradvocacy.ca.

WHO: Dr. David Saltman, MD, PhD, FRCP, Board Member, CACC
Dr. Joseph Ragaz, MD, FRCP, Board Member, CACC
Dr. Pierre Major, MD, Vice-Chair, CACC
Sandi Yurichuk, BS, MBA, Vice-Chair, CACC

Note: Patients will also be available at the news conference for media interviews

Lifelong Prevention Still Key to Beating Skin Cancer

Summertime means plenty of fun in the sun for many. “I would burn on Saturday and Sunday, peel by Wednesday and be back on the water by the next Saturday doing the same thing,” says Thomas Randall, a man in his 70s who spent much of his youth at a lake or a beach trying to tan a pale complexion. But countless hours of sun exposure have taken a toll on his skin, and he now needs regular examinations to search for pre-cancerous moles. “I had two moles cut off my chest and a major incision on my left leg to remove another mole,” Kendall says. He’s also had lesions removed from his face and both ears.

Craig Elmets, M.D., chair of the UAB department of dermatology, says protecting skin from the sun’s ultraviolet radiation, is the number one way to avoid potential skin problems. “Sunscreen should be worn daily and re-applied often, even if the sky is cloudy. A hat and sunglasses with 100 percent UV protection also protect against melanoma, a form of skin cancer than can occur anywhere on the body, even in the eye,” Elmets explains. Keeping a check on moles is also important, and any changes in moles shape, color or texture should be brought to the attention of a dermatologist. Elmets is also researching various drugs to findElmets’ research focuses on drug-based skin-cancer prevention. In 2010 Elmets demonstrated the drug Celebrex may help prevent some non-melanoma skin cancers. Now, he is investigating other medications that could keep skin cancer from developing in patients who are considered high risk due to a personal or family history of the disease. “Our studies are preliminary, but they have been very encouraging and we’ve found that the medications we’ve tested cause a 50 to 60 percent reduction in skin-cancer development,” Elmets says.

Read More

Allergies Treatment News

2011-04-06 / Allergies / No Comment

Nanotechnology research ‘could offer nickel allergy treatment option’

Scientists in the US have devised a potential new method of treating nickel allergies using a special type of nanoparticle.

The team at Brigham and Women’s Hospital have created a cream containing calcium-based particles measuring billionths of a metre in diameter, which can be applied to the skin of those affected by the common dermatological condition.

These particles will capture the nickel contained in everyday objects such as coins and mobile phones, preventing the material from coming into contact with the skin and causing an itchy rash.

According to researchers, the nanoparticles are unable to penetrate the skin, thus making them safer than other treatment options, while the cream itself can be easily washed off with water.

R Rox Anderson, a dermatologist at Harvard Medical School and Massachusetts General Hospital, said: “Nanoparticles that bind to allergens but do not penetrate the skin offer a new strategy. Big hope in a small package!”

According to Allergy UK, sensitivity to nickel mean that reactions are triggered by items such as wristwatches, zippers and scissors, as well as foods including cabbage, rhubarb, oysters and peanuts.

Vaccine in Development Could Cure Cat Allergies

Sniffly-nosed kitten-lovers rejoice: A new vaccine could soon banish allergies to cats.

The vaccine isn’t ready for prime time yet, but a new study finds that the shots are safe, researchers reported March 31 in the Journal of Allergy and Clinical Immunology. They’re also effective at reducing allergic reactions, the researchers reported.

About 10 percent of peopleare allergic to cats. Currently, the only solutions are to stay far away from felines or to get multiple injections of kitty allergens to help the body build up a tolerance. But that process can take years, wrote McMaster University immunologist and study researcher Mark Larche.

Larche and his colleagues developed the vaccine by isolating the protein shed by cats that causes the most allergic reactions. They then used blood samples from people with cat allergies to determine which segment of the cat protein binds to and activates immune cells. (An allergic reaction occurs when the immune system interprets benign substances, such as cat dander, as invaders and launches an attack.)

Next, the researchers made synthetic versions of these segments, called peptides. A mix of seven synthetic peptides makes up the vaccine. The idea, the researchers wrote, is that the immune system will encounter these peptide strands, which fit into the immune cells like a key to a lock, and recognize them as harmless. That action stops the sniffling, sneezing inflammatory response in its tracks, even when the peptides are attached to real cat proteins.

An early clinical trial on 88 patients resulted in no serious side effects, the researchers reported. A single injection reduced the skin’s inflammatory reaction to cat allergens by 40 percent, the researchers wrote. To get an equivalent response with current anti-pollen allergy treatments, they wrote, patients would have to get 12 weeks of treatment with pollen extract.

The vaccine is being developed by Adiga Life Sciences, a company established at McMaster University, and British biotech firm Circassia Ltd. The companies are continuing with clinical trials with a larger group of patients to determine the optimal dose for the vaccine.

Local alternative treatment for allergies

Do you suffer from allergies? Do the budding trees make you cry? Do you reach for drugs or head to the doctor for shots as soon as the grass needs mowing? There is an alternative being offered by a Pittsford chiropractor.

Dr. Ted McArthur has a computer system that can track which allergens you react to (no scratch tests or needle pricks). Then, using specific meridians of the body, he points a low-intensity laser at designated spots for just a few seconds. This is believed to interrupt the biorhythms that set off your allergies. Typically, after eight to 12 laser treatments, he says the majority of his patients report no more symptoms.

Dawn Parkison of Penfield says that she couldn’t even think of mowing her grass without doping up on over-the-counter allergy medicines. But after going through the laser treatment, she realized the stuffy nose and watery eyes she always put up with were gone. “I am symptom-free now and I can even go visit my friend who has a cat! I never could spend much time in her house because of her pets.”
Mexican pharmacy online
Dr. McArthur says he has been using the BAX 3000 system for two years now. He was skeptical at first, but since so many of his patients were suffering from allergies, he decided to test it. “There is maybe one out of 10 patients that doesn’t respond to the laser treatment. But for those who do, they tell me, they’ve stopped using inhalers, some no longer need shots and most of them need much less medication.”

Allergy clinic can help you breathe easier

Springtime is here! The birds are chirping, the bees are buzzing, your eyes are itching and it’s hard to breathe. If this scenario sounds familiar, the Atlanta Allergy & Asthma Clinic can help.

Dr. Stan Fineman, allergist and president-elect of the American College of Allergy, Asthma and Immunology, says it is high time for allergy sufferers due to the pollen count this time of year.

He said problems from respiratory allergies are prevalent. Symptoms include nasal congestion, sneezing, itching of the nose and eyes and sometimes a cough, usually triggered by pollen.

The doctor said in Marietta tree pollen is prevalent in March and grass pollen in April. “Usually, March, April and May are the bad spring season time for pollen allergy sufferers here in Marietta,” Dr. Fineman said.

He said the high pollen count in mid-February was unusual. He says as it gets warmer, pollen counts will continue to increase. “People are going to have a greater problem with their symptoms because of a phenomenon called the priming effect,” he said.

He says when people are re-exposed to an allergen a few weeks after the first occurrence, they have a more violent allergic reaction. “This is a concern with people with seasonal tree pollen allergies,” he said.

The clinic conducts a special allergy skin test using extracts in order to find out what triggers the allergic reaction. Dr. Fineman said, “If somebody is very allergic and their positive to the skin test, and they’re having significant symptoms and trouble, then we can start a medication and use the allergy shot.”

He said allergy injections are a very effective procedure to help patients build up a tolerance toward the allergen. “When they are re-exposed, they won’t have the same symptoms,” he said.

Nancy Wilkins of Dallas said the injections have helped her to get her life back. She said she is allergic to “every tree, every grass, three different types of mold, cats, dogs and dust.”

At this time of year, “Normally I have watery itchy eyes. I can’t breathe,” she said. Wilkins also has allergy-induced asthma. “My nose is stuffed up and I can’t laugh. I can’t talk without coughing,” she said.

Wilkins said at one time she was on two inhalers and taking medications and still had severe symptoms. She was referred to the Atlanta Allergy and Asthma Clinic from a friend whose son’s allergies cleared up after treatment.

“I thought I may as well try this,” Wilkins recalled. “I’ve tried everything else.”

She said her lifelong battle with allergies caused her to develop world allergy syndrome. She was unable to eat food such as watermelon, cantaloupe, nuts, and raw cucumbers.

Wilkins began treatment in 2010. She said when the skin test was conducted on her back, welts rose, indicating certain allergens. Three shots were designed specifically for her.

When she started treatment, Wilkins took two shots per week for five months. It gradually was reduced to one weekly shot, and now she goes in every other week for one shot. She is expected to finish the shots completely within six to eight months.

Wilkins said treatment has helped to her breathe and her symptoms had drastically declined. “Basically, I got my life back,” she said. She is also able to eat foods that were once restricted because of her world allergy syndrome.

Wilkins emphasizes the importance of following treatment all the way through. “Don’t skip any appointments,” she said. “It’s important to keep up with the shots or it won’t work.”

The Atlanta Allergy and Asthma Clinic has been certified by the National Allergy Bureau and is the official pollen reporting station for metro Atlanta.

Read More

Teeth Whitening Today

2011-04-05 / Health News / No Comment

Professional Teeth Whitening is the Easy Way to a Sparkling Smile

A dazzling, white smile can do wonders for a person’s confidence, and always lights up her whole face. Not everyone has naturally white teeth, however. Tooth color varies from one individual to another, and smoking, as well as drinking tea, coffee or red wine can also discolor the enamel over time. Fortunately, there are pleasant and effective whitening procedures such as those offered by a family dentist Kenmore WA area residents often recommend.

The Signature Smiles family dentist office provides a wide range of dental treatments, including various types of cosmetic dentistry. One of the most popular is the in-office teeth whitening therapy that uses high concentration hydrogen peroxide to achieve that bright, white look. The patient’s teeth are treated with the whitening formula while she relaxes by watching a movie or listening to music for around an hour and a half, until her teeth reach the desired shade. The procedure is perfectly safe, and is particularly appreciated for the fact that it results in noticeably whiter teeth after the very first session.

In between office visits, many patients like to maintain their pearly smiles by using the take-home trays they can obtain from their Kirkland dentist. These trays are custom-formed to fit the user’s mouth, but since they contain a lower concentration of the whitening agent they are less effective than professional treatments. Nevertheless, this is a convenient and affordable way to ensure that one’s teeth continue to look their best at all times.

Drs. Dowd and Wu and their professional staff at Signature Smiles work hard to make sure that every patient receives the highest possible level of personalized care. The team at the family dentist Bothell residents have come to favor is a firm believer in the principle of “mind, body and smile.” They know that a person’s oral health, psychological state and overall body condition are all linked, with each system to some extent dependent on the proper functioning of the others. This holistic approach also extends to teeth whitening treatments – after all, a brighter smile brightens the mood too, which can in turn improve physical health and wellbeing.

More information about teeth whitening and other dental procedures available at Signature Smiles is available at MindBodyandSmile.com or on (425) 489-1177.

 

About Signature Smiles
Signature Smiles is an eco-friendly dentist serving families in and around Snohomish County and King County, Washington. Drs. Cristin Dowd and Ken Wu believe in treating each patient as though that person is a member of their own family. Signature Smiles addresses all areas of dentistry for both adults and children, including preventative services, cosmetic dentistry, tooth implants and restorative dentistry.

Cost of One Hour Teeth Whitening With BriteSmile

The technological advancements in science have made it possible for everyone to get affordable dental cosmetic procedures in case of teeth appearance problems. One of the most common dental cosmetic procedure is teeth whitening.

There is a need for white and bright teeth because we are all social creatures. We need to socialize at our workplace, in schools and colleges, parties, meetings, vacation, business tours and whatever you can think of.

There is no big turn off than yellow and stained teeth. So, you can imagine what is at stake. Moreover, it also depicts how much you care about your dental health. So, why give negative vibes when you can get teeth whitening procedure easily and anywhere? One of the most successful teeth whitening procedures available is BriteSmile, cost of which may vary from place to place.

When you opt for this procedure, the difference may be anywhere between eight to fourteen shades. So, it means that BriteSmile teeth whitening procedure is highly effective. Now, the most important thing to consider is BriteSmile cost.

In different parts of United States, you will see difference in BriteSmile cost. Before we venture any further in this topic, let us see how teeth whitening is accomplished using BriteSmile. It does not use laser. In fact, it makes use of a whitening gel and lamp which emits blue frequency gentle light. This light is used for polishing the teeth.

Another important aspect of BriteSmile teeth whitening procedure is whitening gel that is used for process of bleaching. It makes the entire teeth whitening very efficient and safe. Furthermore, the pH value is almost neutral that keeps the agent compatible to enamel of teeth. Now, the gel works with blue light and starts whitening. Entire whitening procedure is completed in one hour and what you get is uniformly white teeth.

Now coming back to the most essential information about this procedure; the BriteSmile cost. To begin with, the cost will depend on what product are you using? You can get BriteSmile pens and toothpaste. They would be affordable to almost everyone. But, if you wish to get this done by a dentist, then the cost may vary depending on the region you are in.

In New York, the BriteSmile procedure cost can be anywhere between $300-1000. So far, BriteSmile teeth whitneing success rate is very high and that is why, people choose New York as a favorite destination for affordable BriteSmile procedure.

If you are in California, then average BriteSmile cost is $600. Almost every dentist would be charging you this amount. So, before you end up at a dentist’s clinic for teeth whitening procedure, double check the cost. If it is higher than this amount, you can always explore other possible locations. This is because at such average rate, quality will not be compromised. So, no need to pay more when you can get same services and results at cheaper value.

The average BriteSmile cost in Seattle is $500. While you can get same services in San Francisco at $300, in Ohio, the BriteSmile cost is more than $600. Again Alabama and Florida will cost you an average of $4-500 but if you are looking for a cheaper option, then Los Angeles is your place. The BriteSmile cost in LA can be as low as $200. Washington DC can also be a part of your favorite destination for BriteSmile treatment as you only need to spend $300 to get sparkling white and bright teeth.

Oral health certificate recommended before teeth whitening

People should get an oral health certificate from their dentist or dental specialist before getting their teeth whitened, the Health and Disability Commissioner says.

The recommendation follows a woman suffering severe mouth pain after having her teeth whitened by an unregistered practitioner.

Before the teeth whitening, the woman had her teeth scaled and polished by a dental hygienist, a report released by the Health and Disability Commissioner today said.

As a result, during the teeth whitening procedure and for two days after, part of her gums turned white, she suffered severe mouth pain and burning gums.

There is no legal requirement for teeth whitening to be performed by a dentist, and the woman knew the practitioner was not a dentist.

The person offering the whitening service was told of the woman’s pain and changed the information given to patients, warning that carrying out teeth whitening too soon after scaling and polishing could result in discomfort. Clients were advised to wait 14 days between the two treatments.

The commissioner recommended those offering teeth whitening services change information given to clients “…to include advice to obtain an oral health certificate from a registered dentist or dentist specialist prior to undergoing teeth whitening”.

However, there remained a risk that patients could be misled by the teeth whitener’s assertions of having professional training and qualifications, and the commissioner asked the Ministry of Health to look into that aspect.

“This case highlights the risks of teeth whitening being carried out by persons who are not qualified to assess consumers’ teeth or form conclusions whether their teeth are suitable for teeth whitening.”

Read More

Hair Loss Treatment News

2011-04-02 / Health News / No Comment

Innovative Hair Loss Treatment at Harley Street Hair Clinic

The Harley Street Hair Clinic is a pioneer of follicular transfer, the latest innovation for the effective treatment of hair loss.

London, United Kingdom, March 16th, 2011 – There are many different kinds of hair loss treatment in the market today, but few have proven as successful as follicular transfer, a minimally invasive, scar free, revolutionary technique that is now available in the UK at the Harley Street Hair Clinic.

The process begins with a free consultation, in which they conduct a thorough analysis of a client’s condition, explain the follicular unit extraction (FUE) process and the implications of surgery, as well as discussing the likely outcomes so that all the clients fully understand their options.

FUE can provide impressive results. Harley Street Hair Clinic’s highly experienced surgeons have been extensively trained in this groundbreaking technique, which is the least invasive form of surgical hair loss treatment and is a significant improvement over the now redundant strip method.

The surgery involves extracting follicles individually from a donor area and replacing them on the balding areas of the scalp. No hairs are wasted, making this the most efficient as well as the most effective technique currently available. We can usually achieve an undetectable, natural look, as the follicles are placed in such a way as to resemble normal hair growth patterns.

Each follicle is precisely plucked out of the donor area, so there is no need to excise skin at the back of the head. There is less trauma than with other hair loss treatment, shorter healing time, no strip scar and no discomfort in the donor area.

Harley Street Hair Clinic’s surgeons have recently featured in a Channel 4 documentary and a Channel 5 news programme about hair loss treatment, as they are at the cutting edge of innovation in this area. They are, after all, the only UK clinic to be completely focussed on this technique. For more details, visit http://www.hshairclinic.co.uk

About Harley Street Hair Clinic

The Harley Street Hair Clinic is the only hair loss clinic in the UK that is dedicated to follicular transfer, a revolutionary technique for restoring hair to the scalp. Its experienced surgeons have been extensively trained around the world in this pioneering procedure, and the clinic has built a strong track record of successful treatments for satisfied customers.

New service for cancer patients

A NEW service is being launched at St John’s Hospital to help cancer patients.

The HeadStrong service, organised by charity, Breast Cancer Care Scotland and delivered in Livingston, teaches patients scarf-tying techniques and offers the chance to try on a range of hats, scarves, fringes and hairpieces as an alternative to wearing a wig.

The new service to help people facing hair loss as a result of cancer treatment will be launched in Livingston today (Thursday).

During each hour-long appointment, people can also find out how to look after their hair and scalp before, during and after treatment and will have the chance to talk through any concerns they have about hair loss with trained volunteers.

Six local volunteers, many of them with a personal experience of cancer and hair loss, will be running HeadStrong sessions every Thursday from 1 to 3.30pm.

Liz Howley, from Livingston, was diagnosed with breast cancer in 2005 and became a volunteer for Breast Cancer Care Scotland.

She said: “I know from my own experience that being diagnosed with breast cancer can be a very frightening and confusing time and that’s why I wanted to become a volunteer – to use my own experience to help people who are going through the same thing.

“The HeadStrong service is brilliant because we can teach people simple ways to boost their confidence and to help them feel that they’re regaining control of their life again.

“The service is not just about practical advice – the volunteers are there to give clients a space to talk about anything worrying them.

“When you’re having cancer treatment it can be hard to get time to yourself in between the medical appointments so we are there to give you a chance to relax.

“People can bring someone with them for support.”

Appointments are open to people with any type of cancer.

The service is completely free, as are all services offered by Breast Cancer Care Scotland.

Tina Gilbert, clinical nurse specialist at the Cancer Care and Chemotherapy Oncology Unit at St John’s Hospital, said she is confident the new service will prove a big help to local patients.

She said: “Hair loss is such a major event for the cancer patients that we see and can affect their self image.

“Through HeadStrong, we will be able to help people through what can be a very difficult period of their cancer treatment.”

Angela Harris, services co-ordinator at Breast Cancer Care Scotland, commented: “This is the seventh HeadStrong we’ve launched in Scotland and we’re very pleased to be able to offer this extremely popular service to people in West Lothian.”

For more information about HeadStrong at St John’s Hospital or to book an appointment, contact the hospital on 01506 522119 or visit www.breastcancercare.org.uk

Flintshire grandmother helps cancer patients deal with hair loss

A GRANDMOTHER who battled cancer is helping others come to terms with losing their hair during treatment.

Iona Roberts, from Holywell, lost her hair when she was treated for breast cancer seven years ago.

And she is now volunteering her time at HeadStrong centres at Wrexham Maelor Hospital and Glan Clwyd Hospital in Bodelwyddan.

Iona, 57, said that when she lost her hair she was most concerned about scaring her young grandson.

“He came into the bedroom one morning and asked where my hair had gone,” Iona said.

“I was wearing a wig until I recovered, so I told him that my hair was magic and I took it off and put it back on again in the morning.”

The new HeadStrong service, which is funded by charity Breast Cancer Care, is being launched to help patients in North Wales cope with the impact of hair loss while undergoing cancer treatment.

Specially trained volunteers – including former cancer patients like Iona – provide advice and people can learn scarf-tying techniques and try on hats and scarves as an alternative to wearing wigs.

“There’s so much a HeadStrong session can teach you,” Iona added.

“When I lost my hair my daughter bought me a silk scarf, but it wouldn’t stay on.

“If sessions like this were available then it would have been really helpful. This is a chance for patients to realise that losing your hair isn’t forever.”

Head of Breast Cancer Care Cymru, Linda McCarthy, said: “For many women the thought of losing their hair can be worse than the idea of having surgery.

“Hair loss can make people feel very vulnerable, so it’s wonderful to be able to offer a service that can help boost confidence and make women feel better about how they look.”

Read More

Diabetes Treatment News

2011-04-01 / Diabetes / No Comment

Bariatric Surgery coming into its own

Earlier this week the International Diabetes Federation (IDF) released a position statement regarding bariatric surgery as an option for Type 2 Diabetes and obesity. According to their distinguished panel of experts, bariatric surgery should now be considered an appropriate treatment option for people with Type 2 diabetes and obesity if treatment goals are not being met by the traditional medical therapies. But, having said that, if you have diabetes and are overweight, don’t rush out to book your surgery just yet. Do your homework on the subject, research your options and seek the advice of your endocrinologist prior to scheduling surgery. There are guidelines and criteria that should be met to be an eligible candidate for bariatric surgery.

Bariatric surgery is not one specific type of surgery, but rather a group of surgeries, all of which are used to treat obesity. Bariatrics is defined as the field of medicine that study’s and treats obesity. Three of the most common types of bariatric surgeries include: Gastric Bypass surgery, Adjustable Gastric Band surgery and Gastric Sleeve surgery (also referred to as Sleeve Gastrectomy).

Gastric Bypass surgery is the oldest of the group and therefore, is the type of bariatric surgery most people are aware of. It involves sectioning off a part of the stomach and rerouting the intestine to that segment of the stomach. Reduction in the stomach’s capacity results in a rapid weight-loss. However, one of the main drawbacks is that the procedure is permanent (non-reversible). Another major complication is nutritional deficiencies that are often associated with this type of surgery.

Adjustable Gastric Band surgery is another type of bariatric surgery that is performed macroscopically. It sections off a small pouch of the upper stomach using an inflatable band that can be adjusted to maximize the person’s weight-loss. The initial weight-loss is slower than with bypass surgery, but is also considered a less invasive procedure. A major benefit is that this type of surgery is reversible. Initial studies found gastric band surgery to be considered very successful. But complaints of weight regain and band complications have led to many people reversing the procedure and or being dissatisfied with the outcome. Band erosion and band slippage are common complications found in several long-term studies.

The final of the three is Gastric Sleeve Surgery. It is a relatively new procedure and is receiving a lot of attention, especially from dissatisfied gastric band patients. The procedure involves either removing part of the stomach (gastrectomy) or folding and suturing of part of the stomach (plication). The result is a smaller sleeve like stomach that holds less food and allows the patient to feel full with decreased caloric intake, which results in weight-loss. The plication technique has the advantage of being reversible, whereas, the gastrectomy approach is of course permanent.

All three of the procedures have received mixed reviews, but obviously the IDF experts feel it is a viable intervention for morbidly obese patients with type 2 diabetes. But, the patient must remember there is no magic bullet (or surgery) regarding weight-loss. Along with the surgery, a commitment to change one’s eating habits; exercise patterns and general lifestyle are crucial to long-term weight-loss success.

These surgical procedures are tools that may help a person lose weight and manage their diabetic condition, but it is imperative that the patient work closely with his or her medical team prior to surgery and during the post-surgical process. If you feel you fit the criteria (outlined by the IDF), make an appointment to see your endocrinologist regarding bariatric surgical options. The experts have stated their position: bariatric surgery is now a viable option in the treatment of type 2 diabetes and obesity, under certain circumstances!

Could the Treatment For Depression Be the Same As the Treatment For Diabetes?

For decades, physicians, mental health experts and individuals have struggled to find answers to the crippling problems of depression. Now, researchers have posed an interesting new theory: insulin.

Researchers at the University of Toronto stated Monday that intriguing new research seems to suggest that insulin has much more impact on the brain and mood disorders than previously thought.

A trial completed in early March at Mount Sinai Hospital in Toronto saw patients with depression being treated with nasal insulin rather than traditional methods. While it’s in the very early days, the results appear to be positive.

The issue with treating mental health is that even the most recent advances in pharmaceutical treatments are no more effective at treating or controlling depression than the drugs on the market in the 1950s. This new research seems to suggest that perhaps a wholesale alteration to treatment approaches are necessary. Part of the urge to point research in this direction was the fact that 50% to 75% of depression and bi-polar patients are either diabetic, obese or overweight. Other research has shown that insulin plays a significant role in the development of the brain and other neurological functions, said Dr. Roger McIntyre, a psychiatrist and University of Toronto researcher.

“If you step out of psychiatry and you look into another area, like diabetes, a condition defined by insulin problems, those individuals on the surface have many of the same problems that our patients have,” he said in the National Post. “They have lots of mood disturbances and cognitive changes and their brains are as affected as our patients.”

Given that this research is in its infancy, it will be years before enough trials can be run to determine a scientifically proven link, and even longer before effective treatments can be based on the research. Still, it’s a hopeful line of attack and one that could bode well for treatments in the future.

Omni Bio Pharmaceutical, Inc’s. CEO Issues Letter to Shareholders

DENVER, March 31, 2011 /PRNewswire/ — Omni Bio Pharmaceutical, Inc. (OTC BB: OMBP), today issued the following letter to shareholders of the Company:

To the Shareholders of Omni Bio Pharmaceutical, Inc.:

I am writing to you having completed my first month as the Chief Executive Officer of Omni Bio Pharmaceutical, Inc., (“Omni”). With our 2011 Fiscal year coming to a close, this is an appropriate juncture to update our shareholders on the basis for my optimism in your Company’s prospects, and to advise you of my initiatives to increase shareholder value. I intend to keep you updated periodically going forward, the timing of which will be dictated by substantive scientific or business developments.

As you may be aware, I served on the Scientific Advisory Board (“SAB”) of Omni for approximately two years prior to accepting the role as CEO of the Company, and I would like to provide you with my observations about the magnitude of this business opportunity and our progress. During my involvement with Omni’s SAB, I became aware of scientific research in animal models related to the potential uses of Alpha 1 antitrypsin (“AAT”) in numerous disease classifications. I believe the results of these animal models are compelling in terms of their potential significance if similar results can be obtained in a human population.

These studies, which were largely conducted by investigators not associated with Omni, but where Omni controls intellectual property, made it clear to me that the opportunity for Omni to advance its intellectual property into a number of additional disease classifications was significant and persuasive. When I was approached by your Board of Directors to assume the Chief Executive Officer role, I believed that Omni’s science had the potential to have a significant impact on human disease.

At this point in my career, I am interested in developing life changing therapies and I believe Omni’s opportunity provides that situation for me.

Omni is involved with the development of intellectual property related to methods of use patent applications and issued patents related to AAT, a human biological that is FDA-approved for the treatment of chronic obstructive pulmonary disease (“COPD”) and emphysema in AAT deficient patients. Because of the approximately 20 year history of AAT being used to treat COPD and Emphysema, AAT has a solid established safety record, and this assisted us in obtaining FDA clearance to begin our trial in Type 1 diabetes within 12 months of its submission to the FDA. We believe that our method of use patent applications will control the treatment of Type 1 diabetes utilizing AAT, should we obtain the requisite FDA approval.

Our most advanced program is our Phase I/II human clinical trial in Type 1 diabetes involving AAT in recently diagnosed patients at the Barbara Davis Center for Childhood Diabetes in Denver at the Anschutz Medical Campus of the University of Colorado Denver. For this trial, we are using a branded formulation of AAT which is being provided by an existing manufacturer. We initiated this clinical trial this past October, and are approaching completion of the young adult population’s infusion stage, before we move into pediatric patients.

Type 1 diabetes is a large market, there are over two million individuals with Type 1 diabetes in the United States, and we believe that 25-30,000 that have been recently diagnosed have residual islet function. There is no effective form of therapy currently available to the market to block this debilitating and life shortening disease. Based on the addressable market size and anticipated cost of the drug, this would approximate a potential US market of $700 million annually, which is larger than the existing market for AAT for the treatment of COPD and emphysema. Our plan is to sublicense our intellectual property rights for diabetes and our other intellectual property disease classifications to one or more of the existing manufacturers of AAT, hence avoiding the capital intensive investment in plant, equipment and associated sales force.

Although there is optimism about our study’s prospects within Omni, we are not alone in our optimism. The Immune Tolerance Network (“ITN”) has initiated a similar trial of AAT utilizing Aralast NP in Type 1 diabetics (http://www.retainstudy.org/). The ITN is a non-profit, government-funded consortium of researchers working together to establish new treatments for diseases of the immune system. The ITN was founded in 1999 by the National Institute of Allergy and Infectious Diseases (a part of the National Institutes of Health ) and receives support from the National Institute of Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation (“JDRF”). The ITN study follows on the heels of two failed Type 1 diabetes studies that had been funded by ITN utilizing other drugs. I consider the Immune Tolerance Network’s decision to invest their resources in this trial as an important endorsement of our concept that AAT is a promising therapy for Type I Diabetes.

In addition to the recently commenced ITN study, Israel’s Kamada, LTD recently filed for an IND utilizing their formulation of AAT on Type 1 diabetes. Kamada received FDA approval for its formulation of AAT this past summer and has become aware of our clinical trial in Type 1 diabetes over the past 15 months. We believe their filing an IND with the FDA is a clear indication that they believe the potential for AAT to treat Type 1 diabetes is significant.

Over the course of the past 12 months Omni has been invited to attend and/or present at a number of conferences which have included the Jefferies 2010 Global Healthcare Conference (New York), the 2011 JP Morgan Healthcare Conference (San Francisco), and the Biotech Showcase-2011 (San Francisco). These conferences have provided us with opportunities to meet with research analysts, investment bankers and potential industry collaborators for Omni. We intend to continue to pursue the regular attendance of investment conference opportunities in our next fiscal year.

In addition, I believe our intellectual property pipeline gives Omni other opportunities for commercialization. During the course of this year, we may initiate additional clinical trials, which are contingent upon the receipt of additional financing. Each of these trials addresses significant disease classifications with potentially larger markets than Type 1 diabetes. Indications such as transplant rejection and the prevention of graft vs host disease are likely to be areas that will gather the most impetus from Omni due to the ability to generate clinically relevant data in short periods of time.

I am enthusiastic about our prospects and look forward to reporting to you periodically on our progress.

Sincerely,

James D. Crapo, MD

Chief Executive Officer

Omni Bio Pharmaceutical, Inc.

About Omni Bio Pharmaceutical, Inc.

Omni Bio Pharmaceutical, Inc. (www.omnibiopharma.com) is an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential. Omni Bio’s core technology and pipeline are based on issued and pending patents licensed from the University of Colorado Denver (“UCD”) and a privately held corporation surrounding the broader therapeutic potential of currently marketed therapies. One of Omni Bio’s lead development programs is evaluating an FDA-approved, off-patent drug, AAT, for the treatment of Type 1 diabetes. Novel discoveries made at UCD indicate that AAT has the potential to address a variety of indications in the areas of bacterial and viral disorders, biohazards, diabetes and transplant rejection. For additional information, please visit www.omnibiopharma.com.

Forward-Looking Statements

Some of the statements made in this press release are forward-looking statements that reflect management’s current views and expectations with respect to future events, including the expansion and commencement of clinical trials and the outcome and expenses of such trials. These forward-looking statements are not a guarantee of future events and are subject to a number of risks and uncertainties, many of which are outside our control, which could cause actual events to differ materially from those expressed or implied by the statements. These risks and uncertainties are based on a number of factors, including but not limited to receipt of adequate funding to expand and commence clinical trials; receipt of applicable regulatory approvals for clinical trials, the risks related to the ownership and enforceability of our licensed intellectual property necessary to conduct the clinical trials and the business risks disclosed in our SEC filings, especially the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Read More

Acne Treatment News

2011-03-31 / Skin Care / No Comment

Largest Survey of its Kind Reveals the Truth About Negative Perceptions of Teenagers With Acne

Largest Survey of its Kind Reveals the Truth About Negative Perceptions of Teenagers With Acne PR Newswire HARROGATE, England, March 30, 2011 HARROGATE, England, March 30, 2011 /PRNewswire/ — The largest survey of its kind in the UK provides a valuable insight into just how teenagers and parents perceive teenagers with acne. The survey report publication coincides with the launch of a new website, http://www.acneacademy.org which will provide invaluable support to acne sufferers and their families. The results of the survey confirm that teenagers with acne are consistently perceived very differently as compared to teenagers without acne. Respondents generally felt that teenagers with acne would be less sociable and less successful. Teenagers with acne suggested that they would offer a lot in return for not having acne; one in two teenagers would stay off facebook for a year if they could get rid of their acne forever! In addition, over a quarter of teens with acne would refuse to have their picture taken and a fifth have untagged photos of themselves on Facebook, while around 15% have airbrushed their image to make sure their acne isn’t visible in photos. “I would even take my mum as my date to the end of year school ball if it meant that my acne would be gone forever!” – Teenager. The survey also revealed that 70% of teenagers with acne have not sought medical advice, yet interestingly of the 30% who had sought medical advice, 91% noticed an improvement to their skin after using a prescription medicine. Results indicated: – That teenagers with acne are perceived less favourably than clear skin teens by both teens and adults and demonstrates how acne may impact tee’s’ opportunities for advancing socially and academically – That many parents appear to have misguided perceptions regarding the extent to which teens are affected by their acne – Living in the digital era of instant photography uploads and social networking could be making the issue of acne so much worse for today’s teenagers than previous generations – That the single biggest issue in the majority of teenagers’ lives is their appearance, well ahead of issues to do with their social life and education – A solid opinion amongst teenagers that their acne was not serious enough to warrant the doctors time – And finally, the panel was surprised that so few seek treatment when there are so many effective treatments for acne, especially given the risk of scarring in serious acne when left untreated “Acne affects almost 80% of adolescents and young adults aged 11 to 30 and can have a major impact on the lives of those affected. It is eminently treatable and I would positively encourage people to seek help from their GP. There is better use of existing treatments and new treatments coming onto the market all the time which work quickly to start clearing the spots associated with acne.” Dr Stephen Kownacki, GP Representative for the Acne Academy and Executive Chairman of the Primary Care Dermatology Society. Teenagers and young adults are the age group most commonly affected by acne and the effects of having acne can be very distressing, leaving a negative effect on people’s lives. Despite the high incidence of acne little research has been conducted to examine the perceptions of both teenagers and parents of teenagers with acne. “As Dermatologists we can control and manage acne effectively. Successful and early treatment will result in improved patient satisfaction, confidence and overall psychological wellbeing.” Dr Alison Layton, Consultant Dermatologist and Chair of the Acne Academy.

At Home Acne Treatment Ideas

Team up the healthiest natural ingredients with these easy-to-create recipes to enjoy the fabulous benefits of these at home acne treatment ideas. Pimples can damage our skin condition, therefore, it is highly recommended to treat them with the most efficient natural skin care remedies, as the ones presented below.

Fighting against the most severe skin problems can be pretty backbreaking, especially if you don’t have the secret weapons to defeat your enemies. Fortunately, the most skilled skin specialists came up with a complete list of inexpensive and efficient methods on how to prevent the appearance of zits. Moreover, you can use these soothing remedies also to get rid of pimples that ruin your flawless appearance. In order to guarantee the success of your complexion spa, it is essential to use only fresh and natural ingredients. Read through the following presentation of at home acne treatment ideas to see whether you have discovered the most simple and beneficial solutions to all your skin dilemmas.

Mint Wash

Use peppermint oil to create a fabulous wash for your damaged skin condition. Grab a medium bowl and mix ½ cup cool water with 1 tsp peppermint oil. Afterwards, add a few mint leaves to make the fusion even more soothing and healing. Cleanse your complexion, then dip a cotton ball into the lotion and apply it to the affected spots. Make sure you wipe your pimples with this mint wash, rather than rub it. Rubbing can do more harm than good to your sensitive skin.

Bean Tea

The name of this remedy might sound pretty strange, but in spite of this, you can create a soothing bean tea without any difficulties. All you have to do is take a medium bowl and boil a package of green beans. Leave it for 10 minutes and add some extra chamomile to it. Let the beans steep until the mixture cools. Put the lotion into a bottle and use it to wash your complexion with it at least three times per week. Use this revolutionary remedy to cure your skin from severe zits.

Olive Oil and Sugar

Use a soothing at home acne remedy to save time and money. In order to create this super-simple zit treatment mix 2 tsp of sugar with 4 drops of olive oil and a little water. Make sure you achieve the desired texture to be able to apply the mixture on your pimples. Thanks to the antibacterial quality of sugar, you’ll have the chance to get rid of zits after a few sessions. Use this healthy facial also to make blemishes disappear and restore the spotless condition of your complexion.

Rose Petals

Roses are not only lovely flowers but also some of the most efficient remedies against acne. Stop the severe acne breakouts by using this useful and simple home pimple treatment. Create a fine paste by crushing 6 rose petals. In order to achieve the ideal texture mix the paste with 1 tbs of honey, 1 tbs of natural yogurt and 2 tbs of rosewater. Mix all the ingredients and use a cotton swab to apply it on your complexion. Tackle the affected sections and make sure you leave on the facial for at least 15 minutes to have the desired results. Finally, wash the paste off with tepid water. Include this beauty ritual in your weekly skin care routine to make sure you have the best protection against pimples.

Fruit Paste

The miraculous combination of berries and citrus fruits can provide you with the secret remedy against acne breakouts. Create the perfect mixture to get rid of inflammation and the painful sensation given by whiteheads and severe zits. The first step towards creating the most soothing treatment for your complexion is to grab a bowl and mash one strawberry. Then add 1 tsp of lemon juice and half a tbs of honey. Mix all the crucial ingredients to get a fine paste you can easily apply on your skin. Use a cotton swab to place the facial on your pimples and on the affected areas and leave it on for 15 minutes. Finish up your skin spa by rinsing off the treatment with tepid water.

Clariant ~ Youth Concept Hair, Skin and Nail Solutions

MUTTENZ, Switzerland—Clariant launched Youth Concepts, its new concept of youth-focused guide recipes for personal care and decorative cosmetics formulators. Youth Concepts provides answers to major issues such as acne and dandruff treatment, sun protection, and the desire for balanced skin or vibrant makeup. The concept covers a broad range of ingredients suited to the sensitivity of young skin to ensure optimal mildness and hair- and skin-friendliness. In addition, the guide recipes embrace young people’s preference for healthier products with fewer preservatives and more natural ingredients that have less of an environmental impact.

Many of the ingredients fall within Clariant’s EcoTain range focusing on naturally derived and sustainable products. Many of the products are approved by ECOCERT®, e.g., its Velsan® SC preservative booster, based on natural raw materials; and Hostacerin® SFO, a co-emulsifier for achieving a healthy skin feel for day and under-eye creams, sunscreens, based on vegetable, renewable and GMO-free sources.

Clariant’s Youth Concepts are formulated for males and females within the 14 to 25 age group. The range includes:

Skin Care
Balanced skin: Hostapon® CT paste provides a mild, creamy, dense foam for facial cleansers, shampoos and shower products that resists hard water for effective dirt removal and pore cleansing. It is suitable for oily skin, preventing skin shine.
Natural and fresh skin feel: Hostapon SG is an amino acid surfactant for EO-free and sulfate-free rinse-off cosmetic formulations, such as facial cleansers, shampoos, shower gels and shaving preparations. Based on the natural occurring amino acid glycine, it creates rich and creamy foams with high rinseability. Lastly, it is free of preservatives.
Anti-acne: Octopirox® is a multi-functional active that provides high efficacy for acne treatment. It is active against bacteria, yeast and mold. After four weeks usage of an emulsion containing 0.3-percent Octopirox, the amount of free fatty acids that support acne growth in sebum was reduced by 40 to 45 percent, showing much lower activity of microorganisms. It has an excellent toxicological profile and is non-halogenated.
Sunscreen: Aristoflex® polymers are easy-to-process rheology modifiers and polymeric emulsifiers for sprayable lotions, gels, gel creams and creams. They have a fast breaking effect on skin that creates a non-sticky, light and silky skin feel for sunscreens, self-tanning and skin whitening formulations, as well as offering thickening and texture enhancement for decorative cosmetics.

Hair Care
Anti-dandruff: Octopirox is a mild anti-dandruff active ingredient for shampoos and leave-on hair treatments. It works on the actual cause of dandruff by curing microbial growth. It is not chlorinated and offers an excellent toxicological profile. Its solubility in surfactants makes it suitable for clear products with no need for additional stabilizers.
Smooth hair: Genamin® conditioners give volume and body to the hair combined with a natural feel.

Make-Up
Gloss/shine: SilCare Silicone WSI is an EO-free water-in-oil/water-in-silicone emulsifier that gives decorative cosmetics a brighter and shiny look by enhancing the shine of pigments. The glossy finish it creates can make eyes and lips look fresher and brighter. The emulsifier adds a smooth and silky feel to formulations and helps to reduce tackiness, resulting in easy spreading and application for all kinds of body lotions, sunscreens and skin care products.

Body
Visually-appealing shower and bath products: Aristoflex TAC creates new sparkling optical effects and stabilizes air bubbles or particles in shower or bath products even at low concentrations. The suspending agent for surfactant systems forms clear and stable gels with a yield force over a wide pH range. It is EO-free and is especially suitable for combination with bio-polymers, creating economic and easy-to-preserve formulations with excellent rheology.

Read More

ADHD News and Treatment

2011-03-30 / Mental Health / No Comment

Dealing with Distractions and Overreactions

More than five million American children and teens have been diagnosed with Attention Deficit/Hyperactivity Disorder, a condition that makes it difficult – if not impossible – to focus and complete tasks. When Katherine Ellison found herself yelling at her son constantly to shut up, she didn’t know that he had ADHD, nor that she had it too. Together, they embarked on a year-long quest to understand the disorder, investigating and trying different treatments. Ellison chronicled their experiences in a new book, Buzz: A Year of Paying Attention.

Buzz Ellison had many problems in elementary school. He could not sit still, and was constantly jumping up and down in class, not paying attention to his teachers, not focusing on the task at hand. As a result, his mother Katherine Ellison says, he was always in trouble.

“His attitude towards school really changed. I think he got bullied both by his peers and his teachers who insisted that he could do things that he really wasn’t capable of doing at that age and remembering things and they gave him a lot of negative feedback,” said Ellison.

Katherine Ellison, a Pulitzer Prize-winning investigative journalist, says she didn’t understand why he behaved like that, and admits, her behavior was also contributing to the situation.

“I was making things worse often by being anxious or being impatient or not understanding him. I realized at some point that I really hadn’t hugged him in a while. I wasn’t smiling when he came into the room because we were having such a hard time,” recalled Ellison.

Buzz was diagnosed with ADHD when he was nine. And, like many parents of children with ADHD, Ellison learned she had the disorder as well. She was in her late 40s.

“It was a great relief to actually get a diagnosis, because I had spent a lifetime really wondering what was going on and why I seem to be different from so many other people I knew,” Ellison noted. “I, like many people with ADD, had a rollercoaster of a life. For instance, I got sued for $11 million for a reporting error that I made in one of my first years as a newspaper reporter. And two years later, I won a Pulitzer Prize. So these are the kinds of things that often happen when you got this disorder; you’re capable of really amazing things and very humiliating, terrible things.”

Ellison and Buzz decided to work together to deal with their disorder and write a book about their experience.

“My son and I started out by writing a contract together, which was terrific because it changed the perspective from being a shameful problem that we had to a joint business project,” explained Ellison. “I also knew that he would cooperate with me. He wanted a percentage of the profits from the book. I was willing to do that because all of a sudden we’re partners rather than antagonists.”

Mother and son delved into the world of ADHD for a year, researching various remedies, specialists and alternative therapies for treatment.

“The two of us spent a lot of time going to neuro-feedback sessions, a process that’s a kind of bio-feedback for the brain where you’re actually conditioning your brain with the help of computers to slow down, become more calm and focused,” said Ellison. “We tried meditation. We both really focused on getting aerobic exercise and we got counseling. And all of these things helped.”

Ellison and Buzz also tried prescription drugs, which doctors often recommend to help youngsters cope with the symptoms of ADHD.

“I was completely against medication,” recalled Ellison. “I thought kids are being over-medicated, which they are, but it turns out that many kids are not getting the help they need. I want to really make clear that I don’t believe meds alone or meds for life are good strategies. And I think that it must be part of a more comprehensive approach.”

Although ADHD is an increasingly common diagnosis, there are many misconceptions about it.

“One of the biggest misconceptions is parents think that this is their fault,” said Peter Levine, a pediatrician in California, who specializes in treating children with ADHD. “Other parents will blame them for it because they see the way these kids acting and they will say, ‘What’s wrong with you? Why can’t you control your child?’ So parents will blame themselves. Another misconception is that the child really is not trying, because oftentimes these kids are trying harder than other kids to control their behaviors. That leads to a lot of frustrations.”

Levine says the first step in dealing with ADHD is getting the facts straight.

“In America, the diagnosis rate in children generally is quoted in the range of about 3 to 7 percent of children,” noted Levine. “It’s more common in boys, by about three to one. This is a highly inheritable disorder. They can’t get over ADHD. I mean it’s not something that you can make go away. As many as two-third of the children who have problems with ADHD will have difficulties as adults. You can’t cure it. You have to find ways of coping with it.”
Canadian pharmacy viagra – www.canadianpharmacynorx.com
One of the most effective ways to do that, he says, is changing ones parenting style. That’s what Katherine Ellison did. She says she is now paying more attention to her son, spending more quality time with him, being less judgmental and giving him more positive feedback. And Buzz is responding with fewer outbursts at home and at school, more focus on doing his school work and a new interest in playing tennis.

Doping or Diet? ADHD Might Be Easily Conquered By Good Food

Along with autism, many people (experts and parents alike) think they know a thing or two about Attention Deficit Hyperactivity Disorder (ADHD). Some will even insist that they know what causes it and how to cure ADHD, which is a developmental disorder characterized by hyperactivity and attentional problems that arise in young children, but can follow them throughout their adult life. But at this point, despite the myriad of theories that swirl around ADHD like a perturbed leaf pile on a blustery afternoon, everything is just conjecture.

However a new theory being floated about holds some true promise to coping and, possibly, dismantling the ADHD cycle. Over five million children ages four to 17 have been diagnosed with ADHD (about ten percent of the children in the U.S.), so a viable solution to this vexing problem is welcome news, especially if the treatment is attainable for all. Dr. Lidy Pelsser of the ADHD Research Centre in the Netherlands, and lead author of a study on food and ADHD, holds true to the idea that ADHD is assuredly easy enough to regulate through a particular, but not unreasonable, diet. As reported in the British journal The Lancet this past February, it was discovered with a restricted diet alone, many children experienced a significant reduction in ADHD symptoms. Pelsser insists that 64 percent of children diagnosed with ADHD are actually experiencing a hypersensitivity to food.

For those that are curious, the diet that Pelsser is advocating is hardly challenging or even expensive. The fairly strict diet utilized in the study consisted of water, rice, turkey, lamb, lettuce, carrots, pears and other hypoallergenic foods – all of which were free of additives, preservatives, or artificial ingredients. According to author Kristin Wartman, writing for the website Civil Eats, There are a multitude of credible scientific studies to indicate that diet plays a large role in the development of ADHD. One study found that the depletion of zinc and copper in children was more prevalent in children with ADHD. Another study found that one particular dye acts as a “central excitatory agent able to induce hyperkinetic behavior.” And yet another study suggests that the combination of various common food additives appears to have a neurotoxic effect—pointing to the important fact that while low levels of individual food additives may be regarded as safe for human consumption, we must also consider the combined effects of the vast array of food additives that are now prevalent in our food supply.

To be clear, Pelsser, and advocates of her findings, are not insisting that drugs like Ritalin, commonly used to treat ADHD, should be wholly dismissed in favor of a few turkey legs and a serving of salad. But modifying a child’s diet should be the first measure taken in dealing with an ADHD diagnosis or symptoms. Some children may not respond at all to the elimination diet, but according to this new data, many will.

Do you think it is enough to change up a child’s diet, eliminating questionable foods and introducing an array of whole foods, or do you think ADHD is a serious disorder that should only be dealt with using psychopharmacology? Is diet really the link to many developmental disorders, not just ADHD?
Eric Steinman is a freelance writer based in Rhinebeck, N.Y. He regularly writes about food, music, art, architecture and culture and is a regular contributor to Bon Appétit among other publications.

Corpus Christi children at forefront of class-action lawsuit targeting foster care system

The state foster care system puts children in harm’s way, mismanages their health care and shuffles them from one location to the next, a lawsuit filed Tuesday in Corpus Christi says.

Two Corpus Christi children are at the forefront of the federal class-action lawsuit that asks for sweeping reforms of the state’s child welfare program, the Department of Family Protective Services. The case, M.D. vs. Perry, names Texas Gov. Rick Perry, Thomas Suehs, executive commissioner of the Health and Human Services Commission; and Anne Heiligenstein, Texas Department of Family and Protective Services commissioner, as defendants.

In a prepared statement, Heiligenstein rejected the lawsuit’s claims of widespread problems and highlighted recent improvements the department has made, including $1 billion in additional funding during the last several years.

“We’re on the right path and will continue to do everything we can to protect Texas children, but I worry that a lawsuit like this will take critical time and resources away from the very children it presumes to help,” she said.

The Corpus Christi children’s stories, and those of seven other children the state shuffled between foster homes, health care facilities and case workers, were highlighted in the lawsuit filed by Children’s Rights, a national child advocacy group based in New York.

The situations described in the lawsuit paint a picture of a system that places children in inappropriate institutions, ignores their mental health needs, overmedicates them and doesn’t look for permanent homes.

“Once children cross the line into permanent foster care, the state essentially gives up on their prospects for ever leaving state custody with permanent families of their own,” said Marcia Robinson Lowry, executive director of Children’s Rights.

One Corpus Christi 14-year-old, identified as M.D., grew up in Corpus Christi and was first placed in state custody when she was 8 years old. The state first placed her in her aunt and uncle’s custody, but she was sexually assaulted by a cousin and removed from that home.

As a 10-year-old, she moved through three foster homes in six months and eventually moved to a treatment facility in Victoria, where she became suicidal. The state later moved her to another treatment center outside of Houston and then another center in Denton.

While there, M.D. walked to a nearby retail center and reported that she was raped. The suit claims M.D. wasn’t given counseling but instead was chastised for leaving the facility and sent to a juvenile detention center after a fight at the treatment center.

The girl now is at a therapeutic placement center in San Antonio where she is denied basic privileges.

“She has no visitors. She cannot have any toiletries.” the lawsuit says. “She is warehoused and alone.”

The lawsuit also details the life of a 16-year-old Corpus Christi boy identified as T.C., who has been in the state’s care for eight years. The state has moved T.C. through at least 20 homes and treatment centers, including one home where he stayed only seven days.

He stayed nearly a year at a treatment center in Victoria when he was 9 years old and was sent to seven different psychiatric and behavioral hospitals as far away as Waco and Tyler.

One treatment center where T.C. lived for a year had a history of licensing violations including accusations that staff members beat, chocked, cut and bruised children and children under its care attempted suicide. At one time, T.C. was sent to an adult jail for throwing a rock at an administration building.

T.C. now lives at a treatment center in Greenville, more than 450 miles away from Corpus Christi. Three of his brothers were adopted by a Corpus Christi family, but he has not been able to visit them, a problem the lawsuit says other children also have.

T.C.’s emotional and psychological health has deteriorated while in the state’s care, the lawsuit alleges, and the boy has been diagnosed with ADHD, depression, bipolar disorder, anxiety and Asperger’s syndrome. More than once, T.C. has run away from a treatment center and tried to admit himself to a hospital.

The statement from Heiligenstein highlights changes the state department has made to address the problems.

The state recently reformed its system, increased its funding, decreased workers’ caseloads and is considering more reforms, Heiligenstein’s statement said.

Adoptions have increased by more than 50 percent in the last six years, and placements of foster children with relatives have increased by 38 percent. The use of psychotropic medications has decreased by 31 percent.

The Texas Legislature is considering a proposed redesign of the Texas foster care system. The proposal would provide homes for foster children closer to their communities, minimize the number of placements, keep brothers and sisters together, and provide financial incentives to reward high-quality foster care providers who move children to permanent homes more quickly, according to Heiligenstein’s statement.

Tags:
Read More

Quit Smoking Today

2011-03-26 / Health News / No Comment

SD Health Department’s quit smoking campaign adds online component

PIERRE, S.D. — The state Health Department is expanding a quit smoking campaign to include a web-based program.

The department said the online program offers information, motivational messages, step-by-step guides and support from others who have quit smoking.

A grant from the U.S. Centers for Disease Control and Prevention pays for the expansion.

The Health Department offers other smoking cessation help through a phone-based service.

A 2008 survey found that 17.5 percent of South Dakotans smoke cigarettes.

“Quitting” video inspires Nunavut students

Students in Nunavut have chosen “Quitting,” a short video filmed by three Inuit youth, as the most powerful story about the challenges and benefits of quitting smoking.

The short video came in first among seven tobacco clips, shown during “the Smoke Stories: Quit Clips by Inuit Youth” video screening contest, organized by the Inuit Tobacco-free Network.

“Quitting,” filmed by three Inuit youth, Kendra Tagoona of Ottawa, Crystal Navratil of Inuvik and Nancy Etok of Kangiqsualujjuaq, includes personal interviews: Vicky Chevrier talks about her feelings when she first saw pictures of a smoker’s lungs; Jeannie Pascal talks about her friend who quit smoking after 46 years; and Mahtoonah Argna’naaq shares how proud she is that her boyfriend is trying to quit.

“It gets easier and easier,” says Chevrier in the vido. “I’m doing everything I possibly can.”

This video also includes black and white images of cigarette packages and vintage footage about the harms of tobacco use.

Thirty-eight classrooms from 12 Nunavut middle and high schools viewed various video clips filmed by Inuit youth for the Inuit Tobacco-free Network, run by the Ottawa-based Inuit Tuttarvingat health organization.

Students then voted for the video which they thought had a powerful enough message to be aired on television. Many held group discussions about issues such as tobacco use, quitting smoking and the effect of second-hand smoke.

Students finally selected “Quitting” as their favourite video clip.

“This contest gave youth a chance to watch people’s stories about their decision to start smoking, the physical and emotional effects of smoking, and what inspired them to quit,” said Dianne Kinnon, the director of Inuit Tuttarvingat, in a March 24 news release.

Classes which participated in the video screening contest could win either a $500 gift card for book purchases or a flip video camera for their class.

Innujaq School in Arctic Bay won the grand prize, a $750 gift certificate to purchase books or equipment.

The filmmakers of the winning video were also awarded prizes for their creativity, the news release said.

Quitting Smoking Before Surgery Not Risky, Study Finds

Doctors can safely recommend that patients quit smoking any time before surgery, according to a new study, Reuters reported March 17.

Past research had suggested that patients who quit smoking in the last few weeks before surgery suffered more post-surgical complications. As a result, some doctors recommend not quitting within eight weeks of a planned surgery.

The new study reviewed the results of nine different studies (and a total of nearly 900 patients) and found that in all of them, patients who quit smoking in the eight weeks before a planned surgery did not have more complications; and one study showed they had fewer complications. Patients who quit more than two months in advance of surgery also had fewer complications.

“It’s certainly better if [patients] quit earlier,” said one of the study’s authors, Dr. Peter Hajek, of Barts and the London School of Medicine and Dentistry in Britain. But quitting any time, he said, was still a good idea.

“Quit early if you can,” he said, “but if you can’t, quitting late is also alright.”

According to the study abstract, “further large studies would be useful to arrive at a more robust conclusion,” but there was no reason doctors should not tell their patients to quit smoking any time prior to surgery.

“We are pretty sure that until some new evidence of harm comes along…there is no sign of any danger,” said Hajek.

Dr. Philip Devereaux disagreed. “It’s not conclusively shown that it is safe to stop smoking prior to surgery,” he said.

Devereaux is a heart doctor and epidemiologist at McMaster University in Ontario who co-authored a comment on the study. He and a colleague wrote that the new analysis did not “definitively answer the question raised,” and that the “optimal timing of smoking cessation for patients seen close to their scheduled surgery awaits further research.”

Hajek and one of his co-authors indicated in disclosure statements appended to the research that they they have consulted with and received research funding from several makers of smoking cessation drugs.

The study, “Stopping Smoking Shortly Before Surgery and Postoperative Complications,” was published online March 14, 2011, in the Archives of Internal Medicine.

canadian generic viagra online
Read More